其他可用于急性缺血性卒中治疗的静脉溶栓药包括瑞替普酶(reteplautomotive service engineers)、尿激酶、乙酰化纤溶酶原链激酶激活复合物（some kind ofistreplautomotive service engineers）和葡激酶。
基于1个网页-相关网页
The recanalization rate at 2 hours after thrombolysis was 86.7% in GBV-PA high-dose group, 88.9% in reteplase group, 57.9% in urokinase group and 0.00% in control group. There was significant difference in each thrombolytics groups compared with the control group.
溶栓后2小时GBV-PA大剂量组、瑞替普酶组、尿激酶组、生理盐水组的血管再通率分别为86.7%、88.9%、57.9%和0.00%,各溶栓剂组与生理盐水对照组比较均有统计学差异。
参考来源 - 短尾蝮蛇毒纤溶酶原激活剂颈内动脉溶栓的实验研究·2,447,543篇论文数据，部分数据来源于NoteExpress
应用推荐